Mark Eisner, M.D., M.P.H.
Board Member
Jade Biosciences, Inc. (JBIO)Equibles does not estimate personal net worth.
Get an email with a short summary when Jade Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get JBIO alertsAbout Mark Eisner, M.D., M.P.H.
Mark Eisner, M.D., M.P.H. is recorded as Board Member at Jade Biosciences, Inc. (JBIO) since June 25, 2026. Jade Biosciences, Inc. reported in an 8-K filed June 26, 2026 that Mark Eisner, M.D., M.P.H. was appointed Class I director, effective June 25, 2026. Jade Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jade Biosciences, Inc. includes Tom Frohlich (CEO and Board Member), Eric Dobmeier (Chairman and Board Member), Bradford Dahms (CFO) and 7 others.
“On June 25, 2026, the Board of Directors (the "Board") of Jade Biosciences, Inc. (the "Company") appointed Mark Eisner, M.D., M.P.H., to serve as a Class I director of the Company, to hold office until the Company's 2028 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier resignation, death or removal.”
Affiliation history
-
Current
2026-06-25–present
Company network
Leadership on record at Jade Biosciences, Inc.
- Tom Frohlich CEO, Board Member
- Eric Dobmeier Chairman, Board Member
- Bradford Dahms CFO
- Benjamin T. Dake COO
- Andrew King CTO
- Elizabeth Balta General Counsel
- Allison Dorval Board Member
- Christopher Cain Board Member
- Continuing Directors Board Member
- Donald J. Santel Board Member